Yogish Kudva
Endocrinology, Diabetes & Metabolism · Rochester, MNNPI 1073586137
Payments from drug & device makers
Across 812 payments — averaging $3611.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1.2M
- Dexcom, Inc.$712K
- Tandem Diabetes Care, Inc.$494K
- Sequel Med Tech, LLC$211K
- Mannkind Corporation$169K
- Novo Nordisk AS$89K
- plus $85K from 6 others
Across 9 payments — averaging $158.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi US Services Inc.$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 108 | $1,172,561 |
| Dexcom, Inc. | 56 | $712,302 |
| Tandem Diabetes Care, Inc. | 4 | $494,388 |
| Sequel Med Tech, LLC | 204 | $210,778 |
| Mannkind Corporation | 16 | $168,549 |
| Novo Nordisk AS | 384 | $88,885 |
| Sanofi US Services Inc. | 2 | $48,042 |
| Novo Nordisk | 17 | $23,040 |
| Vertex | 15 | $10,778 |
| Nestle Healthcare Nutrition Inc. | 1 | $1,800 |
| E.r. Squibb & Sons, L.L.C. | 1 | $1,150 |
| Sanofi-aventis U.S. LLC | 4 | $388 |
How this compares
$2,932,662 in reported general payments places this provider in the 95th percentile of 120 endocrinology, diabetes & metabolism providers in Minnesota.
See all endocrinology, diabetes & metabolism providers in Minnesota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Rochester
- Irina BancosRochester$4.8M
- Marius StanRochester$2.2M
- John MorrisRochester$1.9M
- Adrian VellaRochester$1.7M
- Mabel RyderRochester$691K
- Manpreet MundiRochester$388K
- Bart ClarkeRochester$298K
- Marjorie Ann MalbasRochester$222K
- Robert WermersRochester$188K
- Diane DoneganRochester$175K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.